Bladder cancer biomarkers: Past and future directions.
作者信息
Rodriguez-Homs Miguel, Baack Kukreja Janet
机构信息
Division of Urology University of Colorado Aurora CO USA.
出版信息
BJUI Compass. 2021 Jan 4;2(1):7-8. doi: 10.1002/bco2.61. eCollection 2021 Jan.
Abstract
摘要
相似文献
1
Bladder cancer biomarkers: Past and future directions.膀胱癌生物标志物：过去与未来的方向
BJUI Compass. 2021 Jan 4;2(1):7-8. doi: 10.1002/bco2.61. eCollection 2021 Jan.
2
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.膀胱癌的尿生物标志物：当前研究现状及未来方向综述。
Urol Oncol. 2021 Jan;39(1):41-51. doi: 10.1016/j.urolonc.2020.08.016. Epub 2020 Sep 9.
3
Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.膀胱癌蛋白质组学十年：进展与未来方向
Bladder Cancer. 2017 Jan 27;3(1):1-18. doi: 10.3233/BLC-160073.
4
Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.膀胱癌的微卫星不稳定性分析（MSA）：过去的历史和未来的方向。
Int J Mol Sci. 2021 Nov 28;22(23):12864. doi: 10.3390/ijms222312864.
5
Biomarkers for bladder cancer management: present and future.膀胱癌管理的生物标志物：现状与未来。
Am J Clin Exp Urol. 2014 Apr 5;2(1):1-14. eCollection 2014.
6
Treatment of muscle-invasive and advanced bladder cancer in 2020.2020 年肌层浸润性和晚期膀胱癌的治疗。
CA Cancer J Clin. 2020 Sep;70(5):404-423. doi: 10.3322/caac.21631. Epub 2020 Aug 7.
7
Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future.膀胱癌的膀胱保留治疗：过去、现在和未来。
Jpn J Clin Oncol. 2020 Sep 28;50(10):1097-1107. doi: 10.1093/jjco/hyaa155.
8
The contemporary role and impact of urine-based biomarkers in bladder cancer.尿液生物标志物在膀胱癌中的当代作用及影响
Transl Androl Urol. 2017 Dec;6(6):1031-1042. doi: 10.21037/tau.2017.11.29.
9
Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer.肌层浸润性膀胱癌保留膀胱治疗方法的现状与未来方向。
Curr Treat Options Oncol. 2020 Nov 23;22(1):3. doi: 10.1007/s11864-020-00800-5.
10
Circulating Tumor DNA in Bladder Cancer: Novel Applications and Future Directions.膀胱癌中的循环肿瘤DNA：新应用与未来方向
Eur Urol. 2018 Apr;73(4):541-542. doi: 10.1016/j.eururo.2017.10.011. Epub 2017 Oct 31.
引用本文的文献
1
The great escape: A tale of the visiting professor's Artful Dodge.成功逃脱：一位客座教授巧妙回避的故事。
BJUI Compass. 2021 Jan 26;2(1):3-6. doi: 10.1002/bco2.66. eCollection 2021 Jan.
本文引用的文献
1
Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia.角蛋白 17 是尿路上皮肿瘤的一种敏感且特异的生物标志物。
Mod Pathol. 2019 May;32(5):717-724. doi: 10.1038/s41379-018-0177-5. Epub 2018 Nov 15.
2
Diagnostic Advances in Urine Cytology.尿液细胞学诊断进展
Surg Pathol Clin. 2018 Sep;11(3):601-610. doi: 10.1016/j.path.2018.06.001. Epub 2018 Jul 13.
3
Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients.谁应该接受血尿调查？3556 例当代前瞻性观察研究结果。
Eur Urol. 2018 Jul;74(1):10-14. doi: 10.1016/j.eururo.2018.03.008. Epub 2018 Apr 10.
4
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?膀胱癌的组织学变异：它应如何改变非肌层浸润性和肌层浸润性疾病的治疗策略？
Transl Androl Urol. 2016 Oct;5(5):692-701. doi: 10.21037/tau.2016.06.13.
5
Screening for bladder cancer: recommendation statement.膀胱癌筛查：推荐声明。
Am Fam Physician. 2012 Feb 15;85(4):397-9.
Zotero 插件